Eagle Asset Management Inc. boosted its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 435,718 shares of the biopharmaceutical company’s stock after buying an additional 22,628 shares during the quarter. […]